Skip to main content
Year archive

AVACTA GROUP PLC — 2023 filings

All 45 regulatory filings released by AVACTA GROUP PLC (AVCT) in 2023, sourced directly from the official regulator.

45 Filings
2023 Period
2023 filings (45)
Filing Released Lang
Appointment of Chief Business Officer
Board/Management Information
2023-12-19 English
ALS-6000-101 Phase 1a Study Data
Regulatory Filings
2023-12-13 English
Shareholder update to review AVA6000 Phase 1a data
Regulatory Filings
2023-12-04 English
Block Listing Six Monthly Return
Share Issue/Capital Change
2023-10-27 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2023-10-23 English
Block Listing Application to AIM
Share Issue/Capital Change
2023-10-18 English
Avacta to present at AACR-NCI-EORTC conference
Regulatory Filings
2023-10-05 English
Director/PDMR Shareholding
Remuneration Information
2023-09-29 English
Interim Results for the Period Ending 30 June 2023
Interim / Quarterly Report H1 2023
2023-09-28 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2023-09-20 English
Peel Hunt Appointed as Joint Broker
Capital/Financing Update
2023-09-20 English
Appointment Dr.Christina Coughlin as a consultant
Regulatory Filings
2023-09-20 English
Successful Completion of Sixth Dose Escalation
Regulatory Filings
2023-09-19 English
Notice of Results
Report Publication Announcement
2023-09-06 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2023-07-21 English
Result of Annual General Meeting
AGM Information
2023-06-28 English
Annual General Meeting and Shareholder Event
AGM Information
2023-06-28 English
Completion of Fifth Dose Escalation in AVA6000
Regulatory Filings
2023-06-21 English
Director Appointment
Board/Management Information
2023-06-19 English
Statement regarding market speculation
Capital/Financing Update
2023-06-19 English
AGM and Shareholder Event Detailed Agenda
AGM Information
2023-06-08 English
Second Milestone in AffyXell Joint Venture
M&A Activity
2023-06-05 English
Posting of Annual Report and Notice of AGM
Report Publication Announcement
2023-06-02 English
Avacta acquires Coris Bioconcept
Regulatory Filings
2023-06-01 English
Block Listing Six Monthly Return
Regulatory Filings
2023-04-27 English
First Patient Dosed in the US in AVA6000 Phase 1
Legal Proceedings Report
2023-04-27 English
Preliminary Results
Earnings Release FY 2022
2023-04-25 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2023-04-21 English
AVA3996 data poster presented at AACR
Regulatory Filings
2023-04-17 English
1st US Clinical Investigator AVA6000 Sites Opened
Regulatory Filings
2023-04-06 English
First Patient Dosed in Fifth Cohort of AVA6000
Regulatory Filings
2023-04-05 English
Notice of Results and Investor Presentation
Report Publication Announcement
2023-04-03 English
AVA3996 data poster presentation at AACR
Environmental & Social Information
2023-03-27 English
Statement re: Silicon Valley Bank
Legal Proceedings Report
2023-03-13 English
Avacta Therapeutics Division Science Day
Report Publication Announcement
2023-02-23 English
Issue of Equity and Total Voting Rights
Regulatory Filings
2023-02-13 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2023-01-23 English
Second Price Monitoring Extn
Regulatory Filings
2023-01-17 English
Price Monitoring Extension
Regulatory Filings
2023-01-17 English
Second Price Monitoring Extn
Regulatory Filings
2023-01-17 English
Price Monitoring Extension
Regulatory Filings
2023-01-17 English
Second Price Monitoring Extn
Regulatory Filings
2023-01-17 English
Price Monitoring Extension
Regulatory Filings
2023-01-17 English
Successful Completion of Fourth Dose Escalation
Regulatory Filings
2023-01-17 English
Block Listing Application to AIM
Regulatory Filings
2023-01-16 English